About the Skin Cancers and Grafts Session
Skin cancers, including melanoma and non-melanoma types, pose significant challenges in dermatology. Effective treatment often requires surgical intervention, which may involve excision and grafting techniques to restore the skin’s appearance and function. Grafts, whether autologous (from the patient's own skin) or allogenic (from a donor), play a crucial role in wound healing and minimizing scarring. In cosmetology, the focus is on not just treating skin cancer but also enhancing the aesthetic outcomes post-surgery. Techniques such as skin resurfacing and targeted therapies can help improve skin texture and tone. Ongoing research in dermatology aims to refine grafting procedures and explore advanced options, ensuring that patients receive both effective cancer treatment and optimal cosmetic results. This integrated approach is essential for promoting physical and emotional well-being in individuals affected by skin cancer.
Featured Speakers — Skin Cancers and Grafts 2027
Speaker lineup for this track will be announced soon.
Browse all speakers →Recent Research Presented at Skin Cancers and Grafts Sessions
Selected abstracts from this track will be published here.
Related Scientific Sessions at IDC 2027
Why Attend the Skin Cancers and Grafts Conference 2027
Present Your Research
Oral and poster slots for original Skin Cancers and Grafts work, reviewed by the scientific committee.
Network Globally
Meet researchers, clinicians, and industry leaders from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Skin Cancers and Grafts research and practice.
Hybrid Flexibility
Attend in person in Rome or join virtually — same program, same certificate.
Join IDC 2027 for the Skin Cancers and Grafts track
Oral and poster slots for your work — in person in Rome or online. Not presenting? Attend as a delegate to learn from the field.
Skin Cancers and Grafts Conference 2027 — FAQs
What is the Skin Cancers and Grafts track at IDC 2027?
The Skin Cancers and Grafts track is a dedicated stream within IDC 2027 covering the latest research, clinical innovation, and best practice in Skin Cancers and Grafts. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Skin Cancers and Grafts sessions?
Researchers, clinicians, educators, doctoral students, and industry leaders with an interest in Skin Cancers and Grafts are all welcome — whether presenting or attending.
Can I present my research in the Skin Cancers and Grafts track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Skin Cancers and Grafts sessions?
Yes. IDC 2027 is a hybrid conference — attend the Skin Cancers and Grafts track in person in Rome or join live online, with on-demand access afterward.
Join the IDC 2027 delegation
Rome · June 21–23, 2027 · Hybrid · in-person & virtual
Attend without presenting.